LECOMPTE A. S.
- Country
- France
- Department
- INFECTIOLOGIE
Research Overview
- Evaluation of Immunogenicity and Safety of 20-Valent Pneumococcal Conjugate Vaccine During Acute Febrile Illness in Adults at Risk for Pneumococcal Infection
- A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persistent infection with HPV Types 16, 18, 31, 33, 45, 52, or 58 in adult males, 20 to 45 years of age
Data & Insights
Has run more than one trial at 3 of 43 partner sites.
Specializations
Infectious Disease Prevention
The investigator specializes in studying pneumococcal infection prevention, with particular emphasis on high-risk and medium-risk patient populations.
- Pneumococcal Vaccine Research
- Immunization During Acute Illness
- Vaccine Safety Studies
Their work focuses on understanding immune responses in patients with varying risk levels for invasive infections.
Immunology
The investigator conducts research in vaccine immunogenicity, examining immune system responses under different clinical conditions.
- Immune Response Assessment
- Conjugate Vaccine Studies
- Vaccination Timing Research
Their expertise extends to studying immune responses during and after acute febrile conditions.
Preventive Medicine
The investigator's work encompasses vaccination strategies for vulnerable populations requiring specialized preventive care.
- Risk-Based Prevention
- Vaccination Protocol Development
- Patient Safety Assessment
Their research aims to optimize vaccination timing for enhanced patient protection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.